Literature DB >> 23340209

Mediator MED23 regulates basal transcription in vivo via an interaction with P-TEFb.

Wei Wang1, Xiao Yao, Yan Huang, Xiangming Hu, Runzhong Liu, Dongming Hou, Ruichuan Chen, Gang Wang.   

Abstract

The Mediator is a multi-subunit complex that transduces regulatory information from transcription regulators to the RNA polymerase II apparatus. Growing evidence suggests that Mediator plays roles in multiple stages of eukaryotic transcription, including elongation. However, the detailed mechanism by which Mediator regulates elongation remains elusive. In this study, we demonstrate that Mediator MED23 subunit controls a basal level of transcription by recruiting elongation factor P-TEFb, via an interaction with its CDK9 subunit. The mRNA level of Egr1, a MED23-controlled model gene, is reduced 4-5 fold in Med23 (-/-) ES cells under an unstimulated condition, but Med23-deficiency does not alter the occupancies of RNAP II, GTFs, Mediator complex, or activator ELK1 at the Egr1 promoter. Instead, Med23 depletion results in a significant decrease in P-TEFb and RNAP II (Ser2P) binding at the coding region, but no changes for several other elongation regulators, such as DSIF and NELF. ChIP-seq revealed that Med23-deficiency partially reduced the P-TEFb occupancy at a set of MED23-regulated gene promoters. Further, we demonstrate that MED23 interacts with CDK9 in vivo and in vitro. Collectively, these results provide the mechanistic insight into how Mediator promotes RNAP II into transcription elongation.

Entities:  

Keywords:  Egr1; Mediator MED23; P-TEFb; basal transcription; elongation

Mesh:

Substances:

Year:  2013        PMID: 23340209      PMCID: PMC3644042          DOI: 10.4161/trns.22874

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  54 in total

Review 1.  Transcriptional regulation and the role of diverse coactivators in animal cells.

Authors:  Robert G Roeder
Journal:  FEBS Lett       Date:  2005-02-07       Impact factor: 4.124

Review 2.  Multiple functions of general transcription factors TFIIE and TFIIH in transcription: possible points of regulation by trans-acting factors.

Authors:  Y Ohkuma
Journal:  J Biochem       Date:  1997-09       Impact factor: 3.387

Review 3.  The general transcription factors of RNA polymerase II.

Authors:  G Orphanides; T Lagrange; D Reinberg
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

Review 4.  Transcriptional activation by recruitment.

Authors:  M Ptashne; A Gann
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

5.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.

Authors:  D L Bentley; M Groudine
Journal:  Nature       Date:  1986 Jun 12-18       Impact factor: 49.962

6.  NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation.

Authors:  Y Yamaguchi; T Takagi; T Wada; K Yano; A Furuya; S Sugimoto; J Hasegawa; H Handa
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

7.  DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs.

Authors:  T Wada; T Takagi; Y Yamaguchi; A Ferdous; T Imai; S Hirose; S Sugimoto; K Yano; G A Hartzog; F Winston; S Buratowski; H Handa
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

8.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.

Authors:  M E Garber; P Wei; V N KewalRamani; T P Mayall; C H Herrmann; A P Rice; D R Littman; K A Jones
Journal:  Genes Dev       Date:  1998-11-15       Impact factor: 11.361

9.  Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.

Authors:  Annemieke A Michels; Alessandro Fraldi; Qintong Li; Todd E Adamson; François Bonnet; Van Trung Nguyen; Stanley C Sedore; Jason P Price; David H Price; Luigi Lania; Olivier Bensaude
Journal:  EMBO J       Date:  2004-06-17       Impact factor: 11.598

10.  The RNA polymerase II molecule at the 5' end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged.

Authors:  A E Rougvie; J T Lis
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

View more
  27 in total

1.  The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination.

Authors:  Xiao Yao; Zhanyun Tang; Xing Fu; Jingwen Yin; Yan Liang; Chonghui Li; Huayun Li; Qing Tian; Robert G Roeder; Gang Wang
Journal:  EMBO J       Date:  2015-09-01       Impact factor: 11.598

2.  Transcriptional Elongation of HSV Immediate Early Genes by the Super Elongation Complex Drives Lytic Infection and Reactivation from Latency.

Authors:  Roberto Alfonso-Dunn; Anne-Marie W Turner; Pierre M Jean Beltran; Jesse H Arbuckle; Hanna G Budayeva; Ileana M Cristea; Thomas M Kristie
Journal:  Cell Host Microbe       Date:  2017-04-12       Impact factor: 21.023

Review 3.  MYC and transcription elongation.

Authors:  Peter B Rahl; Richard A Young
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 4.  Targeting Cancer Cells with BET Bromodomain Inhibitors.

Authors:  Yali Xu; Christopher R Vakoc
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

5.  Retroviral cyclin controls cyclin-dependent kinase 8-mediated transcription elongation and reinitiation.

Authors:  Claire H Birkenheuer; Connie D Brewster; Sandra L Quackenbush; Joel Rovnak
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

6.  Increased unfolded protein responses caused by MED17 mutations.

Authors:  Takeshi Terabayashi; Satoru Hashimoto
Journal:  Neurogenetics       Date:  2021-08-15       Impact factor: 2.660

7.  Histone cross-talk connects protein phosphatase 1α (PP1α) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomain-containing 4 (BRD4) for inducible gene expression.

Authors:  Xiangming Hu; Xiaodong Lu; Runzhong Liu; Nanping Ai; Zhenhua Cao; Yannan Li; Jiangfang Liu; Bin Yu; Kai Liu; Huiping Wang; Chao Zhou; Yu Wang; Aidong Han; Feng Ding; Ruichuan Chen
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

8.  BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements.

Authors:  Anand S Bhagwat; Jae-Seok Roe; Beverly Y L Mok; Anja F Hohmann; Junwei Shi; Christopher R Vakoc
Journal:  Cell Rep       Date:  2016-04-07       Impact factor: 9.423

9.  Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor.

Authors:  T K Albert; C Rigault; J Eickhoff; K Baumgart; C Antrecht; B Klebl; G Mittler; M Meisterernst
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

10.  Med23 Regulates Sox9 Expression during Craniofacial Development.

Authors:  S Dash; S Bhatt; K T Falcon; L L Sandell; P A Trainor
Journal:  J Dent Res       Date:  2020-11-06       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.